Effects of Inositol Hexaphosphate and Myo-Inositol Administration in Breast Cancer Patients during Adjuvant Chemotherapy

Background: Treatment of breast cancer (BC) includes locoregional and systemic therapies depending on tumor and patient’s characteristics. Inositol hexaphosphate (IP6) is known as a strong antioxidant agent, able to improve local (i.e., breast region) side effects, functional status and quality-of-l...

Full description

Bibliographic Details
Main Authors: Maria Ida Amabile, Alessandro De Luca, Domenico Tripodi, Elena D’Alberti, Rossella Melcarne, Giovanni Imbimbo, Orietta Picconi, Vito D’Andrea, Massimo Vergine, Salvatore Sorrenti, Alessio Molfino
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/11/8/756